Medical Technologies (MedTech) stories
Life sciences firms could avoid costly FDA review delays as the software flags conflicting claims across filings before submissions are sent.
Rising US and Asia-Pacific demand lifted first-quarter revenue 22% at SOPHiA GENETICS, as genomic analyses hit a record 108,000.
Adoption is rising as customers report faster fixes and lower running costs, with one college cutting troubleshooting time by 90%.
Pharmaceutical field teams could cut hours of searching to seconds as ACTO's new system routes approved information through compliance checks.
The rollout will save dentists time on notes and letters as PortmanDentex broadens AI scribe use across UK and Ireland practices.
Early US traction could help Vertigenius turn remote vertigo monitoring into broader clinic adoption after securing EUR 2.55 million.
The enlarged group now spans more than 90 plants in 22 countries, giving customers broader support across aerospace, medical and semiconductor markets.
The award gives each student EUR €2,500 plus mentoring and placements, extending a five-decade partnership between the university and Stryker.
Underserved Indian communities could gain easier access to early screening as the platform links symptom checks with more than 30 kiosk tests.
Healthtech startups are finding it harder to scale as weaker exits and tighter liquidity help drive Canadian VC investment down to CAD $1 billion in 2025.
The AUD $490 million Waterloo precinct is set to ease Sydney’s lab space shortage as it moves into delivery with major global partners.
The funding could help turn hospital infusions into self-injectable treatments, as the London-founded firm scales microgravity drug crystallisation.
App-based marketplaces and telehealth tools are easing Australia’s doctor shortage, giving locums more control while improving care in remote areas.
A record CAD $1.52 million finale in Vancouver underlined growing support for women founders as three businesses shared the top prize.
Early demand for Nosebuds has been reinforced by Gold and Red Dot honours, boosting Goodair’s bid to scale its drug-free breathing device.
The move gives UK life sciences firms a new source of scale-up capital as a funding gap has left many promising businesses short of backing.
The new unit aims to ease pressure on strained care services by testing tools that could cut hospital use and staff shortages.
Patients at risk of deterioration are being monitored at home as trusts seek to cut admissions and ease a 7.2 million-case backlog.
Investors overseeing USD $350 billion in assets will join more than 300 startups in Singapore as AI shifts towards industrial uses.
Australian people with type 1 diabetes can now choose a smaller sensor that reduces finger-prick checks and links to an insulin pump.